The global burden of chromoblastomycosis.

Daniel Wagner de Castro Lima Santos Conceição de Maria Pedrozo E Silva de AzevedoVania Aparecida VicenteFlávio de Queiroz Telles Anderson Messias Rodrigues Gerrit Sybren de Hoog David William DenningArnaldo Lopes Colombo

Published in: PLoS neglected tropical diseases (2021)

This review represents our current knowledge on the burden of CBM world-wide. The global incidence remains unclear and local epidemiological studies are required to improve these data, especially in Africa, Asia, and Latin America. The recognition of CBM as NTD emphasizes the need for public health efforts to promote support for all local governments interested in developing specific policies and actions for preventing, diagnosing and assisting patients.

Keyphrases

public health
end stage renal disease
risk factors
ejection fraction
newly diagnosed
healthcare
chronic kidney disease
peritoneal dialysis
electronic health record
big data
patient reported outcomes
machine learning
deep learning
data analysis
case control